CD14 and long COVID-19: In particular, this work highlights a distinctive CD14+STAT2high monocyte subset in non-elderly female patients with PASC, emphasizing an overactive type I interferon pathway and a possible type I interferonopathy underlying the pathogenesis of PASC occurring among non-elderly female patients.